[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Viral Vectors and Plasmid DNA Manufacturing Market Growth (Status and Outlook) 2024-2030

January 2024 | 130 pages | ID: GA5CBC1005AEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Viral Vectors and Plasmid DNA Manufacturing market size was valued at US$ 594.8 million in 2023. With growing demand in downstream market, the Viral Vectors and Plasmid DNA Manufacturing is forecast to a readjusted size of US$ 1971.6 million by 2030 with a CAGR of 18.7% during review period.

The research report highlights the growth potential of the global Viral Vectors and Plasmid DNA Manufacturing market. Viral Vectors and Plasmid DNA Manufacturing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Viral Vectors and Plasmid DNA Manufacturing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Viral Vectors and Plasmid DNA Manufacturing market.

The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.

Global Viral Vectors and Plasmid DNA Manufacturing key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.

North America is the largest market, with a share about 50%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.

In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections , etc.

Key Features:

The report on Viral Vectors and Plasmid DNA Manufacturing market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Viral Vectors and Plasmid DNA Manufacturing market. It may include historical data, market segmentation by Type (e.g., Plasmid DNA, Viral Vectors), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Viral Vectors and Plasmid DNA Manufacturing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Viral Vectors and Plasmid DNA Manufacturing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Viral Vectors and Plasmid DNA Manufacturing industry. This include advancements in Viral Vectors and Plasmid DNA Manufacturing technology, Viral Vectors and Plasmid DNA Manufacturing new entrants, Viral Vectors and Plasmid DNA Manufacturing new investment, and other innovations that are shaping the future of Viral Vectors and Plasmid DNA Manufacturing.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Viral Vectors and Plasmid DNA Manufacturing market. It includes factors influencing customer ' purchasing decisions, preferences for Viral Vectors and Plasmid DNA Manufacturing product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Viral Vectors and Plasmid DNA Manufacturing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Viral Vectors and Plasmid DNA Manufacturing market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Viral Vectors and Plasmid DNA Manufacturing market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Viral Vectors and Plasmid DNA Manufacturing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Viral Vectors and Plasmid DNA Manufacturing market.

Market Segmentation:

Viral Vectors and Plasmid DNA Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Plasmid DNA
  • Viral Vectors
Segmentation by application
  • Cancers
  • Inherited Disorders
  • Viral Infections
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • BioReliance
  • Cobra Biologics
  • Oxford BioMedica
  • UniQure
  • FinVector
  • MolMed
  • MassBiologics
  • Richter-Helm
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Aldevron
  • Eurogentec
  • Cell and Gene Therapy Catapult
  • Biovian
  • Thermo Fisher Scientific (Brammer Bio)
  • VGXI
  • PlasmidFactory
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size 2019-2030
  2.1.2 Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Type
  2.2.1 Plasmid DNA
  2.2.2 Viral Vectors
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
  2.3.1 Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Viral Vectors and Plasmid DNA Manufacturing Segment by Application
  2.4.1 Cancers
  2.4.2 Inherited Disorders
  2.4.3 Viral Infections
  2.4.4 Others
2.5 Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
  2.5.1 Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2019-2024)

3 VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET SIZE BY PLAYER

3.1 Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Players
  3.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2019-2024)
  3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VIRAL VECTORS AND PLASMID DNA MANUFACTURING BY REGIONS

4.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions (2019-2024)
4.2 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Growth (2019-2024)
4.3 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Growth (2019-2024)
4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth (2019-2024)
4.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
5.2 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024)
5.3 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024)
6.2 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024)
6.3 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Viral Vectors and Plasmid DNA Manufacturing by Country (2019-2024)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024)
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET FORECAST

10.1 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Regions (2025-2030)
  10.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Regions (2025-2030)
  10.1.2 Americas Viral Vectors and Plasmid DNA Manufacturing Forecast
  10.1.3 APAC Viral Vectors and Plasmid DNA Manufacturing Forecast
  10.1.4 Europe Viral Vectors and Plasmid DNA Manufacturing Forecast
  10.1.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Forecast
10.2 Americas Viral Vectors and Plasmid DNA Manufacturing Forecast by Country (2025-2030)
  10.2.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.2.2 Canada Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.2.3 Mexico Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.2.4 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.3 APAC Viral Vectors and Plasmid DNA Manufacturing Forecast by Region (2025-2030)
  10.3.1 China Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.3.2 Japan Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.3.3 Korea Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.3.4 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.3.5 India Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.3.6 Australia Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.4 Europe Viral Vectors and Plasmid DNA Manufacturing Forecast by Country (2025-2030)
  10.4.1 Germany Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.4.2 France Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.4.3 UK Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.4.4 Italy Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.4.5 Russia Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Forecast by Region (2025-2030)
  10.5.1 Egypt Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.5.2 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.5.3 Israel Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.5.4 Turkey Viral Vectors and Plasmid DNA Manufacturing Market Forecast
  10.5.5 GCC Countries Viral Vectors and Plasmid DNA Manufacturing Market Forecast
10.6 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Type (2025-2030)
10.7 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 BioReliance
  11.1.1 BioReliance Company Information
  11.1.2 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 BioReliance Main Business Overview
  11.1.5 BioReliance Latest Developments
11.2 Cobra Biologics
  11.2.1 Cobra Biologics Company Information
  11.2.2 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Cobra Biologics Main Business Overview
  11.2.5 Cobra Biologics Latest Developments
11.3 Oxford BioMedica
  11.3.1 Oxford BioMedica Company Information
  11.3.2 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Oxford BioMedica Main Business Overview
  11.3.5 Oxford BioMedica Latest Developments
11.4 UniQure
  11.4.1 UniQure Company Information
  11.4.2 UniQure Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 UniQure Main Business Overview
  11.4.5 UniQure Latest Developments
11.5 FinVector
  11.5.1 FinVector Company Information
  11.5.2 FinVector Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 FinVector Main Business Overview
  11.5.5 FinVector Latest Developments
11.6 MolMed
  11.6.1 MolMed Company Information
  11.6.2 MolMed Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 MolMed Main Business Overview
  11.6.5 MolMed Latest Developments
11.7 MassBiologics
  11.7.1 MassBiologics Company Information
  11.7.2 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 MassBiologics Main Business Overview
  11.7.5 MassBiologics Latest Developments
11.8 Richter-Helm
  11.8.1 Richter-Helm Company Information
  11.8.2 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Richter-Helm Main Business Overview
  11.8.5 Richter-Helm Latest Developments
11.9 FUJIFILM Diosynth Biotechnologies
  11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
  11.9.2 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
  11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.10 Lonza
  11.10.1 Lonza Company Information
  11.10.2 Lonza Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Lonza Main Business Overview
  11.10.5 Lonza Latest Developments
11.11 Aldevron
  11.11.1 Aldevron Company Information
  11.11.2 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Aldevron Main Business Overview
  11.11.5 Aldevron Latest Developments
11.12 Eurogentec
  11.12.1 Eurogentec Company Information
  11.12.2 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Eurogentec Main Business Overview
  11.12.5 Eurogentec Latest Developments
11.13 Cell and Gene Therapy Catapult
  11.13.1 Cell and Gene Therapy Catapult Company Information
  11.13.2 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Cell and Gene Therapy Catapult Main Business Overview
  11.13.5 Cell and Gene Therapy Catapult Latest Developments
11.14 Biovian
  11.14.1 Biovian Company Information
  11.14.2 Biovian Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 Biovian Main Business Overview
  11.14.5 Biovian Latest Developments
11.15 Thermo Fisher Scientific (Brammer Bio)
  11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Information
  11.15.2 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.15.4 Thermo Fisher Scientific (Brammer Bio) Main Business Overview
  11.15.5 Thermo Fisher Scientific (Brammer Bio) Latest Developments
11.16 VGXI
  11.16.1 VGXI Company Information
  11.16.2 VGXI Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.16.4 VGXI Main Business Overview
  11.16.5 VGXI Latest Developments
11.17 PlasmidFactory
  11.17.1 PlasmidFactory Company Information
  11.17.2 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
  11.17.4 PlasmidFactory Main Business Overview
  11.17.5 PlasmidFactory Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Plasmid DNA
Table 3. Major Players of Viral Vectors
Table 4. Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
Table 7. Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2019-2024)
Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Player (2019-2024)
Table 12. Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Products Offered
Table 13. Viral Vectors and Plasmid DNA Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Regions (2019-2024)
Table 18. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Country (2019-2024)
Table 22. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
Table 24. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2019-2024)
Table 26. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Region (2019-2024)
Table 28. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
Table 30. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2019-2024)
Table 32. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Country (2019-2024)
Table 34. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
Table 36. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Viral Vectors and Plasmid DNA Manufacturing
Table 45. Key Market Challenges & Risks of Viral Vectors and Plasmid DNA Manufacturing
Table 46. Key Industry Trends of Viral Vectors and Plasmid DNA Manufacturing
Table 47. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. BioReliance Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 52. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 53. BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. BioReliance Main Business
Table 55. BioReliance Latest Developments
Table 56. Cobra Biologics Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 57. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 58. Cobra Biologics Main Business
Table 59. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Cobra Biologics Latest Developments
Table 61. Oxford BioMedica Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 62. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 63. Oxford BioMedica Main Business
Table 64. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Oxford BioMedica Latest Developments
Table 66. UniQure Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 67. UniQure Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 68. UniQure Main Business
Table 69. UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. UniQure Latest Developments
Table 71. FinVector Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 72. FinVector Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 73. FinVector Main Business
Table 74. FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. FinVector Latest Developments
Table 76. MolMed Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 77. MolMed Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 78. MolMed Main Business
Table 79. MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. MolMed Latest Developments
Table 81. MassBiologics Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 82. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 83. MassBiologics Main Business
Table 84. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. MassBiologics Latest Developments
Table 86. Richter-Helm Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 87. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 88. Richter-Helm Main Business
Table 89. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Richter-Helm Latest Developments
Table 91. FUJIFILM Diosynth Biotechnologies Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 92. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 93. FUJIFILM Diosynth Biotechnologies Main Business
Table 94. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 96. Lonza Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 97. Lonza Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 98. Lonza Main Business
Table 99. Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Lonza Latest Developments
Table 101. Aldevron Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 102. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 103. Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Aldevron Main Business
Table 105. Aldevron Latest Developments
Table 106. Eurogentec Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 107. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 108. Eurogentec Main Business
Table 109. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Eurogentec Latest Developments
Table 111. Cell and Gene Therapy Catapult Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 112. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 113. Cell and Gene Therapy Catapult Main Business
Table 114. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Cell and Gene Therapy Catapult Latest Developments
Table 116. Biovian Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 117. Biovian Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 118. Biovian Main Business
Table 119. Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Biovian Latest Developments
Table 121. Thermo Fisher Scientific (Brammer Bio) Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 122. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 123. Thermo Fisher Scientific (Brammer Bio) Main Business
Table 124. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Thermo Fisher Scientific (Brammer Bio) Latest Developments
Table 126. VGXI Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 127. VGXI Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 128. VGXI Main Business
Table 129. VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. VGXI Latest Developments
Table 131. PlasmidFactory Details, Company Type, Viral Vectors and Plasmid DNA Manufacturing Area Served and Its Competitors
Table 132. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Offered
Table 133. PlasmidFactory Main Business
Table 134. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. PlasmidFactory Latest Developments

LIST OF FIGURES

Figure 1. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Viral Vectors and Plasmid DNA Manufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Country/Region (2023)
Figure 8. Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2023
Figure 10. Viral Vectors and Plasmid DNA Manufacturing in Cancers
Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market: Cancers (2019-2024) & ($ Millions)
Figure 12. Viral Vectors and Plasmid DNA Manufacturing in Inherited Disorders
Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Market: Inherited Disorders (2019-2024) & ($ Millions)
Figure 14. Viral Vectors and Plasmid DNA Manufacturing in Viral Infections
Figure 15. Global Viral Vectors and Plasmid DNA Manufacturing Market: Viral Infections (2019-2024) & ($ Millions)
Figure 16. Viral Vectors and Plasmid DNA Manufacturing in Others
Figure 17. Global Viral Vectors and Plasmid DNA Manufacturing Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2023
Figure 19. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Player in 2023
Figure 20. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size 2019-2024 ($ Millions)
Figure 22. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size 2019-2024 ($ Millions)
Figure 23. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2019-2024 ($ Millions)
Figure 25. Americas Viral Vectors and Plasmid DNA Manufacturing Value Market Share by Country in 2023
Figure 26. United States Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Region in 2023
Figure 31. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2023
Figure 32. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2023
Figure 33. China Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Country in 2023
Figure 40. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 56. APAC Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 57. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 59. United States Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 60. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 63. China Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 64. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 65. Korea Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 67. India Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 68. Australia Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 69. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 70. France Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 71. UK Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 72. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 73. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 74. Spain Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 77. Israel Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Viral Vectors and Plasmid DNA Manufacturing Market Size 2025-2030 ($ Millions)
Figure 80. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Application (2025-2030)


More Publications